Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.600.530.420.490.32

What is the latest Fixed Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Fixed Capital/Sales ratio of BLISS GVS PHARMA is 0.60 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.60
Mar20230.53
Mar20220.42
Mar20210.49
Mar20200.32

How is Fixed Capital/Sales of BLISS GVS PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.6
13.21
Mar2023 0.53
26.19
Mar2022 0.42
-14.29
Mar2021 0.49
53.13
Mar2020 0.32 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Fixed Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,241.6 Cr -3.5% -1.3% -2.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-3.5%

-1.3%

-2.9%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses